The U.S. Food and Drug Administration has approved Galderma's Nemluvio (nemolizumab) for the treatment of moderate-to-severe atopic dermatitis in patients aged 12 years and older.

Hidradenitis Suppurativa (HS) is a chronic inflammatory skin condition that disproportionately affects women and people of color. It begins in adolescence and can be debilitating, negatively impacting ...

The acne lesions characteristic of Behçet's syndrome are not sterile and are commonly observed in combination with arthritis. The two main nodular skin lesions—superficial thrombophlebitis and ...

If your lips are very dry and cracked, start by using a damp washcloth to buff away dead skin, Marmon says. Then apply a ...

Research shows that certain foods and ingredients can trigger acne symptoms. Here is a list of foods associated with skin ...

L1-blocking antibody is now approved for metastatic or locally advanced cutaneous SCC in adults who are not candidates for curative surgery or curative radiation.

Hand, foot and mouth disease (HFMD) is a very common viral infection that predominantly affects children under the age of 5, ...

A monoclonal antibody that targets interleukin (IL)-31 receptor alpha, nemolizumab is specifically indicated for individuals ...